DENMARK - Monitor Clipper leads financing round in CMC Biologies

The financing is part of the company’s financial strategy in connection with its recent acquisition of Seattle-based ICOS Biologics Manufacturing which was announced in December 2007.

Copenhagen-headquartered CMC provides biopharmaceutical development and manufacturing services. It specialises in services for the scale-up and cGMP manufacture of protein therapeutics for pre-clinical, clinical trials and in-market production.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• Nordics